State Controller Calls for Audit Of Stem Cell Institute's Expenditures
By Joyce E. Cutler,
Bureau of National Affairs
| 11. 29. 2007
[Quotes CGS's Jesse Reynolds]
California Controller John Chiang (D) Nov. 28 called for an audit of all proceeds of the California Institute for Regenerative Medicine (CIRM), the voter-created office overseeing $3 billion in bonds sold to fund stem cell research.
Chiang announced the audit while chairing the annual meeting of the Citizens Financial Accountability Oversight Committee with results due in time for the committee's meeting next spring.
The controller, noting that $250 million in bonds already were sold, directed his staff to audit grant management, financial risk, expenditures, and procedures for avoiding conflicts of interest.
Chiang also asked the state Fair Political Practices Commission (FPPC) for a full review of whether Independent Citizens' Oversight Committee member John Reed violated conflict-of-interest rules. Reed wrote a letter asking why CIRM denied a grant to a scientist who works for him at the Burnham Institute for Medical Research in La Jolla, Calif.
The ICOC is CIRM's governing board. Members are required to refrain from participating in or influencing decisions involving their employers. No changes resulted from Reed's letter, interim CIRM President Richard Murphy said.
Chiang said it...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...